Stocks and Investing Stocks and Investing
Wed, March 29, 2023

Danielle Antalffy Initiated (TNDM) at Hold and Held Target at $45 on, Mar 29th, 2023


Published on 2024-10-28 02:27:52 - WOPRAI, Danielle Antalffy
  Print publication without navigation


Danielle Antalffy of UBS, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Hold and Held Target at $45 on, Mar 29th, 2023.

Danielle has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 2 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $40 on, Thursday, February 23rd, 2023
  • Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023


These are the ratings of the 3 analyists that currently disagree with Danielle


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $47 on, Friday, February 24th, 2023
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023
Contributing Sources